RAIN Rain Oncology Inc.

-

Rain Oncology Inc. Reported Earnings

Friday, August 14, 2026 · 12:00 AM ET

Rain Oncology Inc. (RAIN) reported a loss of $0.40 per share on revenue of $0.00 million for the . .

Rain Oncology Inc. is a late-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.40)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth-207.7 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth